Behçet's disease in Familial Mediterranean Fever:Characterization of the association between the two diseases

https://doi.org/10.1016/S0049-0172(00)80015-3Get rights and content

Abstract

Objectives:

Familial Mediterranean fever (FMF) is a genetic disease, characterized by attacks of fever and painful manifestations. Several vasculitides are more common in FMF than in the general population. The aim of the study was to define and characterize the association between FMF and Behçet's disease (BD), a form of vasculitis not previously related to FMF.

Methods:

We conducted a retrospective study in which FMF patients, alsosuffering from BD (FMF-BD), were recruited from about 4,000 patients registered in our clinic, using a computer survey. Patients identified by the screening process were examined, and those meeting the published criteria for the diagnoses of FMF and BD were classified as FMF-BD cases and compared with unselected FMF and BD controls.

Results:

The prevalence of BD was higher in FMF than in populations knownto be rich in BD (eg, 16 per 4,000 in FMF compared with 1 per 104 in Japan, P < .001). FMF-BD cases and FMF or BD controls were comparable in most demographic, clinical, and laboratory aspects studied. However, more cases than FMF-controls were of Iraqi/Turkish origin and responded less favorably to colchicine. A higher proportion of cases than BD controls had skin, central nervous system, and gastrointestinal manifestations, originated from North Africa, and had family history of BD. In most cases, as in most respective controls, the severity of FMF was of intermediate grade and the extensiveness of BD was limited. The HLA 135 antigen was present in 53% of BD cases and 40% of BD controls.

Conclusions:

BD should be included among the vasculitides complicating FMF BD and FMF in patients with FMF-BD, and in patients suffering from each of these entities alone, are clinically and demographically comparable.

References (51)

  • ShohatM. et al.

    Familial Mediterranean fever: analysis of inheritance and current linkage data

    Am J Med Genet

    (1992)
  • DanielsM. et al.

    Familial Mediterranean fever: high gene frequency among the non-Ashkenazi and Ashkenazi Jewish populations in Israel

    Am J Med Genet

    (1995)
  • LivnehA. et al.

    The changing face of familial Mediterranean fever

    Semin Arthritis Rheum

    (1996)
  • EshelG. et al.

    Acute orchitis in familial Mediterranean fever

    Ann Intern Med

    (1988)
  • ZemerD. et al.

    A controlled trial of colchicine in preventing attacks of familial Mediterranean fever

    N Engl J Med

    (1974)
  • ZemerD. et al.

    Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever

    N Engl J Med

    (1986)
  • The International IMF Consortium

    Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever

    Cell

    (1997)
  • The French FMF Consortium

    A candidate gene for familial Mediterranean fever

    Nat Genet

    (1997)
  • HamuryudanV. et al.

    Behçet syndrome

    Rheumatology in Europe

    (1997)
  • O'DuffyJ.D.

    Behçet's disease

    Curr Opin Rheumatol

    (1994)
  • BrautbarC. et al.

    A genetic study of Behçet disease in Israel

    Tissue Antigens

    (1978)
  • ChajekT. et al.

    Behçet's disease: report of 41 cases and review of the literature

    Medicine

    (1978)
  • WrightV.A. et al.

    Behçet syndrome

    Bull Rheum Dis

    (1978–1979)
  • SwissaM. et al.

    Determination of autoantibodies in patients with familial Mediterranean fever and their first degree relatives

    J Rheumatol

    (1991)
  • EhrenfeldM. et al.

    Is familial Mediterranean fever an autoimmune disease or an immune mediated condition?

  • Cited by (0)

    1

    Heller Institute of Medical Research (HIMR), Sheba Medical Center (SMC), Tel-Hashomer

    2

    Senior Lecturer, HIMR, SMC, Tel-Hashomer,and Sackler Faculty of Medicine (SFM), Tel-Aviv University (TAU), Tel-Aviv

    3

    Senior Lecturer, HIMR, SMC Tel-Hashomer, and SFM, TAU, Tel-Aviv

    4

    Professor of pediatrics, Tissue typing unit, SMC, Tel-Hashomer,and SFM, TAU, Tel-Aviv

    5

    Professorof Medicine, HIMR, SMC, Tel-Hashomer, and SFM, TAU, Tel-Aviv

    6

    Associate Professor of Medicine, HIMR, SMC, Tel-Hashomer, and SFM, TAU, Tel-Aviv, Israel.

    View full text